CD40LG and COVID-19: From the analysis of 348 SARS-CoV-2 infected patients in Northern America and 1,548 blood samples collected prior COVID-19 outbreak, RBD-based ELISA had a high sensitivity of 95% for IgG, 90% for IgA and 81% for IgM for detecting infected individuals [27].